» Articles » PMID: 36235952

L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine

Overview
Publisher MDPI
Date 2022 Oct 14
PMID 36235952
Authors
Affiliations
Soon will be listed here.
Abstract

The present study evaluates the use of thiolized chitosan conjugates (CS) in combination with two fundamental carbon nanoforms (carbon dots (CDs) and Hierarchical Porous Carbons (HPC)) for the preparation of intranasally (IN) administrated galantamine (GAL) nanoparticles (NPs). Initially, the modification of CS with L-cysteine (Cys) was performed, and the successful formation of a Cys-CS conjugates was verified via H-NMR, FTIR, and pXRD. The new Cys-CS conjugate showed a significant solubility enhancement in neutral and alkaline pH, improving CS's utility as a matrix-carrier for IN drug administration. In a further step, drug-loaded NPs were prepared via solid-oil-water double emulsification, and thoroughly analyzed by SEM, DLS, FTIR and pXRD. The results showed the formation of spherical NPs with a smooth surface, while the drug was amorphously dispersed within most of the prepared NPs, with the exemption of those systems contianing the CDs. Finally, in vitro dissolution release studies revealed that the prepared NPs could prolong GAL's release for up to 12 days. In sum, regarding the most promising system, the results of the present study clearly suggest that the preparation of NPs using both Cys-CS and CDs results in a more thermodynamically stable drug dispersion, while a zero-order release profile was achieved, which is essential to attain a stable in vivo pharmacokinetic behavior.

Citing Articles

Cysteine Conjugation: An Approach to Obtain Polymers with Enhanced Muco- and Tissue Adhesion.

Chroszcz-Porebska M, Gadomska-Gajadhur A Int J Mol Sci. 2024; 25(22).

PMID: 39596243 PMC: 11594736. DOI: 10.3390/ijms252212177.


Chitosan Nanoparticles for Intranasal Drug Delivery.

Omidian H, Gill E, Chowdhury S, Cubeddu L Pharmaceutics. 2024; 16(6).

PMID: 38931868 PMC: 11206675. DOI: 10.3390/pharmaceutics16060746.


L-Cysteine-Modified Transfersomes for Enhanced Epidermal Delivery of Podophyllotoxin.

Niu J, Yuan M, Chen J, Wang L, Qi Y, Bai K Molecules. 2023; 28(15).

PMID: 37570682 PMC: 10420961. DOI: 10.3390/molecules28155712.

References
1.
Hakimi S, Mortazavian E, Mohammadi Z, Samadi F, Samadikhah H, Taheritarigh S . Thiolated methylated dimethylaminobenzyl chitosan: A novel chitosan derivative as a potential delivery vehicle. Int J Biol Macromol. 2016; 95:574-581. DOI: 10.1016/j.ijbiomac.2016.10.094. View

2.
Ways T, Lau W, Khutoryanskiy V . Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems. Polymers (Basel). 2019; 10(3). PMC: 6414903. DOI: 10.3390/polym10030267. View

3.
Hanafy A, Farid R, Helmy M, ElGamal S . Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer's disease management. Drug Deliv. 2016; 23(8):3111-3122. DOI: 10.3109/10717544.2016.1153748. View

4.
Rui L, Xie M, Hu B, Zhou L, Saeeduddin M, Zeng X . Enhanced solubility and antioxidant activity of chlorogenic acid-chitosan conjugates due to the conjugation of chitosan with chlorogenic acid. Carbohydr Polym. 2017; 170:206-216. DOI: 10.1016/j.carbpol.2017.04.076. View

5.
Kafedjiiski K, Krauland A, Hoffer M, Bernkop-Schnurch A . Synthesis and in vitro evaluation of a novel thiolated chitosan. Biomaterials. 2004; 26(7):819-26. DOI: 10.1016/j.biomaterials.2004.03.011. View